Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

INTACT-HIP: INTravenous Acetaminophen vs. Oral Randomized Controlled Trial in HIP Fracture Patients - a Feasibility Trial

NCT05425355 is registered in ClinicalTrials.gov with University Health Network, Toronto as lead sponsor.

NCT NCT05425355
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05425355 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
INTACT-HIP: INTravenous Acetaminophen vs. Oral Randomized Controlled Trial in HIP Fracture Patients - a Feasibility Trial
Lead sponsor
University Health Network, Toronto
Phase
Phase 4
Overall status
Recruiting
Start date
January 23, 2023
Completion date
December 30, 2026
Enrollment
42 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hip-fracture, surgery